Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06763965 | Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. | enrolling by invitation | Phase 1 / Phase 2 | 30 | Beijing Bio-Targeting Therapeutics Technology Co., LtdINDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT07126990 | Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma | enrolling by invitation | Phase 1 / Phase 2 | 40 | Xiaorong WuINDUSTRY | 1 | Mar 23, 2026 |
| clinicaltrials |
| NCT07488572 | Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study | enrolling by invitation | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT07483034 | Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment. | enrolling by invitation | N/A | 90 | Brigita VilcOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07226180 | Development and Application of Patient-Derived Models of Cancer | enrolling by invitation | — | 40 | Certis Oncology Solutions, IncINDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06650748 | Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer(NeoMARS) | enrolling by invitation | Phase 2 | 100 | Peking UniversityOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT06474091 | Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) | enrolling by invitation | — | 100 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07474051 | Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials(PERSIST) | enrolling by invitation | — | 178 | AvenCell Therapeutics, Inc.INDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07470658 | Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy | enrolling by invitation | — | 1,274 | National Taiwan University HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT05332054 | Long-Term Follow-up Study(LTFS) | enrolling by invitation | — | 150 | Caribou Biosciences, Inc.INDUSTRY | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07465497 | Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer | enrolling by invitation | N/A | 80 | Instituto Jalisciense de CancerologiaOTHER_GOV | 1 | Mar 12, 2026 | clinicaltrials |
| NCT00587314 | The Effect of Ablation Therapy on Barrett's Esophagus(ablation IN BE) | enrolling by invitation | — | 600 | Mayo ClinicOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06191185 | IMProving Adherence to Colonoscopy Through Teams and Technology(IMPACTT) | enrolling by invitation | N/A | 2,000 | University of California, San FranciscoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05160480 | A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG | enrolling by invitation | — | 9 | University of California, DavisOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07080463 | Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest(VascuLens RCT) | enrolling by invitation | Phase 1 | 60 | University of British ColumbiaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07049822 | Optimising Mammography Screening Accuracy With Blood-based Biomarkers(OPTIMA) | enrolling by invitation | — | 1,200 | Vejle HospitalOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT06508138 | Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection(J21112LINKED) | enrolling by invitation | Phase 1 | 24 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07454941 | Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics | enrolling by invitation | — | 4,000 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06238661 | Prostate Cancer Screening: a Pilot Study(ProScreenMRI) | enrolling by invitation | N/A | 4,500 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07026370 | Chinese Population Health and Multimorbidity Study(CPHMS) | enrolling by invitation | — | 50,991 | China-Japan Friendship HospitalOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT05948618 | Improving PRO for Patients With Cancer Using ECAs and Data Visualization(ECA-PRO Aim 3) | enrolling by invitation | N/A | 100 | Tufts Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT05195515 | The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life(CONQUER) | enrolling by invitation | — | 2,000 | Aarhus University HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07444099 | Early Postoperative Intervention in Gastric Cancer Patients | enrolling by invitation | N/A | 264 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT06624189 | Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis | enrolling by invitation | — | 1,300 | NYU Langone HealthOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT05441475 | A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients | enrolling by invitation | Phase 2 | 118 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07429760 | Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery | enrolling by invitation | N/A | 60 | Shaukat Khanum Memorial Cancer Hospital & Research CentreOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07422727 | Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy(COOLVAS) | enrolling by invitation | N/A | 40 | Sligo General HospitalOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07417774 | Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic(RESTORE LB) | enrolling by invitation | — | 40 | NuvOx LLCINDUSTRY | 1 | Feb 18, 2026 | clinicaltrials |
| NCT04996316 | MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals | enrolling by invitation | — | 1,141 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07409298 | Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy | enrolling by invitation | N/A | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07410403 | AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities(AI) | enrolling by invitation | — | 10 | Fuling ZhouOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT06730685 | Sarcopenia and Cachexia in Patients With Lung Cancer(PHILUCA) | enrolling by invitation | — | 160 | Zealand University HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07401498 | Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC).(LNDNSCLC-RUS) | enrolling by invitation | N/A | 1,000 | Regional Clinical Oncology DispensaryOTHER_GOV | 1 | Feb 10, 2026 | clinicaltrials |
| NCT01173341 | Cardiotoxicity of Cancer Therapy (CCT) | enrolling by invitation | — | 700 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06250777 | Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases(ELPIS) | enrolling by invitation | Phase 2 | 27 | Yonsei UniversityOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06332131 | Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | enrolling by invitation | — | 25 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07390565 | YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer | enrolling by invitation | N/A | 308 | LI FENGOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07395505 | Postoperative Results and Outcomes in Surgical Pelvic Exenteration(PROS-PE) | enrolling by invitation | — | 24 | Chang Gung Memorial HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT04357574 | Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19(CORONA-SHIELD) | enrolling by invitation | — | 1,000 | Duke UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06061328 | Project OASIS: Optimizing Approaches to Select Implementation Strategies(OASIS) | enrolling by invitation | N/A | 8,020 | VA Office of Research and DevelopmentFED | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07363980 | Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study(COTIRA) | enrolling by invitation | — | 4,000 | Ellen Margrethe HaugeOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07383298 | Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase | enrolling by invitation | — | 100 | Qian JiangOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07380867 | Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.(Tattooing) | enrolling by invitation | N/A | 30 | Seoul St. Mary's HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07373951 | Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis(DL-DriverBM) | enrolling by invitation | — | 380 | Ming YangOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376629 | A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC | enrolling by invitation | Phase 2 | 60 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376681 | Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health | enrolling by invitation | — | 2,000 | Taizhou HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376980 | The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer(MST) | enrolling by invitation | N/A | 450 | Korea University Anam HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06370416 | the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib | enrolling by invitation | Phase 2 | 41 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 28, 2026 | clinicaltrials |
| NCT02081755 | Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer | enrolling by invitation | Phase 4 | 336 | Baylor Research InstituteOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07085494 | Neurofeedback and Cognitive Training for PBTS | enrolling by invitation | N/A | 50 | The University of Hong KongOTHER | 1 | Jan 27, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Mar 23, 2026source: clinicaltrials